Study of Nab-Paclitaxel and Gemcitabine With or Without Tocilizumab in Pancreatic Cancer Patients
Conditions
- Unresectable Pancreatic Carcinoma
Interventions
- DRUG: Tocilizumab
- DRUG: Gemcitabine
- DRUG: nab-Paclitaxel
Sponsor
Herlev Hospital
Collaborators